Physician profile
Mark Wolgin
NPI 1780668780
$3,353.32
in general payments reported to CMS, 2019-2025
27 companies · $43.68 in 2025
The $43.68 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $310 · 2020: $220 · 2021: $247 · 2022: $555 · 2023: $483 · 2024: $1,495 · 2025: $43.68.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,013 · Food and Beverage: $1,008.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,012.98 |
| Food and Beverage | $1,008.23 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zimmer Biomet Holdings, INC. | $693.57 | 2020-2024 | Avenir |
| Spineology INC. | $632.50 | 2024 | Optimesh Expandable Interbody Fusion System |
| Organogenesis INC. | $427.56 | 2020-2023 | Puraply |
| Djo, LLC | $416.70 | 2019-2025 | Cmf |
| Boston Scientific Corporation | $229.67 | 2021-2022 | |
| Medtronic, INC. | $209.47 | 2022-2025 | O-Arm, Cd Horizon Spinal System |
| Nevro Corp. | $110.47 | 2023 | Senza |
| Bioventus LLC | $77.76 | 2023-2024 | Exogen Ultrasound Bone Healing System, Durolane |
| Depuy Synthes Sales INC. | $76.34 | 2019-2020 | |
| Globus Medical, INC. | $71.83 | 2022 | |
| Pacira Pharmaceuticals Incorporated | $61.97 | 2021-2023 | Zilretta, Exparel |
| Pacira Therapeutics, INC. | $46.05 | 2020-2021 | |
| Si-Bone, INC. | $34.14 | 2019-2020 | |
| Stryker Corporation | $26.22 | 2021 | |
| Nalu Medical, INC. | $26.12 | 2022 |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Baxter Healthcare | $26.11 | 2022 | |
| Moximed, INC | $22.30 | 2024 | Misha Knee System, Small, Left |
| Ultragenyx Pharmaceutical INC. | $21.82 | 2022 | |
| Amgen INC. | $20.04 | 2019 | |
| Innovation Technologies INC | $19.69 | 2024 | Irrisept |
| Medline Industries Lp | $18.41 | 2024 | |
| Spine Wave, INC. | $16.27 | 2019 | |
| Sanofi-Aventis U.S. LLC | $14.67 | 2019 | |
| Kyocera Medical Technologies, INC. | $14.49 | 2020 | |
| Baudax Bio INC. | $14.44 | 2021 | |
| Misonix INC | $12.37 | 2020 | |
| Medtronic USA, INC. | $12.34 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Wolgin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.